Search Results for 'Crospon'

Dr John O’Dea, president of Engineers Ireland, has called on the Government to prioritise investment in regenerative medicine manufacturing technology for the next generation of job creation.

Galwayman, Dr John O’Dea, president of Engineers Ireland, has called on the Government to prioritise investment in regenerative medicine manufacturing technology for the next generation of job creation.

John O’Dea, CEO of Galway-based Crospon and new president of Engineers Ireland, has said that the health of Ireland’s €7.9 billion medical devices export sector is hugely dependent on the expertise and ready supply of skilled engineers.

Galway-based medical device firm Crospon has this week announced that it has received clearance from the Food and Drug Administration (FDA) in the US for the first use of its EndoFLIP system in gastroenterology applications.

Crospon, the Galway-based medical device developer, has got clearance from the US Food and Drugs Administration (FDA) to market a new imaging catheter for the measurement of sleeves created during bariatric [weight loss] surgery.

Galway-based medical device developer Crospon this week announced that its drug delivery technology platform has been spun out into a distinct company, Janisys, as a result of the continued development of the product prototype.

Galway-based medical device developer Crospon this week announced that its drug delivery technology platform has been spun out into a distinct company, Janisys, as a result of the continued development of the product prototype.

A Galway-based medical company has set up a new business which will eventually see all needles eliminated from the injecting of drugs.

The announcement last week that Galway is to gain 90 new IT related jobs in two separate announcements by Hewlett Packard and Buy.com is a timely reminder that, despite all the doom and gloom, Galway and the western region still has a strong and thriving technology industry.

Local medical device developer Crospon has reason to celebrate on the double with the news that it has secured an additional €2 million in funding and that its flagship gastroenterology product has received clearance from the US Food and Drugs Administration.